Vafidemstat (ORY-2001)
98%
- Product Code: 109881
CAS:
1357362-02-7
| Molecular Weight: | 336.395 g./mol | Molecular Formula: | C₁₉H₂₀N₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Vafidemstat (ORY-2001) is primarily being investigated for its potential in treating central nervous system disorders. It is currently under clinical trials for conditions such as Alzheimer's disease, aggression in patients with psychiatric disorders, and multiple sclerosis. The compound targets specific epigenetic mechanisms, aiming to modulate gene expression associated with these diseases. Its application focuses on reducing neuroinflammation and improving cognitive and behavioral symptoms, offering a novel approach to managing complex neurological and psychiatric conditions.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿156,000.00 |
+
-
|
Vafidemstat (ORY-2001)
Vafidemstat (ORY-2001) is primarily being investigated for its potential in treating central nervous system disorders. It is currently under clinical trials for conditions such as Alzheimer's disease, aggression in patients with psychiatric disorders, and multiple sclerosis. The compound targets specific epigenetic mechanisms, aiming to modulate gene expression associated with these diseases. Its application focuses on reducing neuroinflammation and improving cognitive and behavioral symptoms, offering a novel approach to managing complex neurological and psychiatric conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :